West Pharmaceutical Services - WST Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for West Pharmaceutical Services in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" WST shares.
View WST analyst ratings or view top-rated stocks.

West Pharmaceutical Services' stock was trading at $469.01 on January 1st, 2022. Since then, WST shares have decreased by 28.0% and is now trading at $337.75.
View the best growth stocks for 2022 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, October 27th 2022.
View our WST earnings forecast.

West Pharmaceutical Services, Inc. (NYSE:WST) released its earnings results on Thursday, July, 28th. The medical instruments supplier reported $2.47 earnings per share (EPS) for the quarter, topping the consensus estimate of $2.19 by $0.28. The medical instruments supplier had revenue of $771.30 million for the quarter, compared to the consensus estimate of $754.25 million. West Pharmaceutical Services had a trailing twelve-month return on equity of 29.08% and a net margin of 23.41%. The firm's quarterly revenue was up 6.6% on a year-over-year basis. During the same period last year, the company earned $2.46 EPS.
Read the conference call transcript.

West Pharmaceutical Services announced a quarterly dividend on Thursday, April 28th. Shareholders of record on Wednesday, July 20th will be paid a dividend of $0.18 per share on Wednesday, August 3rd. This represents a $0.72 annualized dividend and a dividend yield of 0.21%. The ex-dividend date of this dividend is Tuesday, July 19th.
Read our dividend analysis for WST.

West Pharmaceutical Services (NYSE:WST) pays an annual dividend of $0.72 per share and currently has a dividend yield of 0.21%. The company has been increasing its dividend for 29 consecutive years, indicating the company has a strong committment to maintain and grow its dividend. The dividend payout ratio is 7.99%. This payout ratio is at a healthy, sustainable level, below 75%. Based on earnings estimates, WST will have a dividend payout ratio of 7.31% next year. This indicates that the company will be able to sustain or increase its dividend.
Read our dividend analysis for WST.

West Pharmaceutical Services issued an update on its FY 2022 earnings guidance on Thursday, August, 4th. The company provided earnings per share guidance of $9.00-$9.15 for the period, compared to the consensus estimate of $9.32. The company issued revenue guidance of $2.95 billion-$2.98 billion, compared to the consensus revenue estimate of $3.05 billion.

107 employees have rated West Pharmaceutical Services Chief Executive Officer Eric M. Green on Glassdoor.com. Eric M. Green has an approval rating of 75% among the company's employees. 60.0% of employees surveyed would recommend working at West Pharmaceutical Services to a friend.

Based on aggregate information from My MarketBeat watchlists, some companies that other West Pharmaceutical Services investors own include NVIDIA (NVDA), Johnson & Johnson (JNJ), AbbVie (ABBV), Walt Disney (DIS), Home Depot (HD), Visa (V), Alibaba Group (BABA), McDonald's (MCD), Netflix (NFLX) and PepsiCo (PEP).

West Pharmaceutical Services trades on the New York Stock Exchange (NYSE) under the ticker symbol "WST."

West Pharmaceutical Services' stock is owned by many different institutional and retail investors. Top institutional shareholders include Franklin Resources Inc. (3.74%), Brown Advisory Inc. (1.46%), California Public Employees Retirement System (0.74%), Riverbridge Partners LLC (0.73%), ProShare Advisors LLC (0.66%) and Sumitomo Mitsui Trust Holdings Inc. (0.60%). Insiders that own company stock include Annette F Favorite, David A Montecalvo, George Lloyd Miller, Patrick J Zenner, Quintin J Lai and Silji Abraham.
View institutional ownership trends.

Shares of WST stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of WST stock can currently be purchased for approximately $337.75.

West Pharmaceutical Services (NYSE:WST) has a market capitalization of $25.01 billion and generates $2.83 billion in revenue each year. The medical instruments supplier earns $661.80 million in net income (profit) each year or $9.01 on an earnings per share basis.

The company employs 10,065 workers across the globe.

West Pharmaceutical Services was founded in 1923.

West Pharmaceutical Services' mailing address is 530 HERMAN O. WEST DRIVE, EXTON PA, 19341. The official website for the company is www.westpharma.com. The medical instruments supplier can be reached via phone at (610) 594-2900, via email at quintin.lai@westpharma.com, or via fax at 800-345-9800.